Researchers of McMaster University and the University of Toronto have developed a promising immunotherapy treatment for a deadly form of adult brain cancer called glioblastoma.
May 27, 2020
0
936
People who walk, cycle and travel by train to work are at reduced risk of early death or illness compared with those who commute by car.
May 19, 2020
0
1053
Adoptive T cell therapies, including chimeric antigen receptor (CAR) T cell therapy, which use genetically engineered killer immune T cells, are emerging forms of immunotherapy that redirect the immune system to target cancer.
May 19, 2020
0
80
Two pediatric brain cancers that are challenging to treat if they recur, medulloblastoma and ependymoma, are the target of a clinical trial using a new type of therapy. A multi-institutional, international team led by researchers ...
Apr 27, 2020
0
136
Men pose more risk to other road users than women do and they are more likely to drive more dangerous vehicles, reveals the first study of its kind, published online in the journal Injury Prevention.
Apr 6, 2020
6
217
Two University of Rochester physicians—one as an investigator and one as a patient—had major roles in a cutting-edge clinical trial using the body's own immune cells to fight late-stage cancer. The striking results, showing ...
Apr 3, 2020
0
143
Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but has faced challenges in targeting solid tumors. Now researchers from the Perelman School of Medicine at the University of Pennsylvania ...
Mar 23, 2020
0
396
How does the brain form "fear memory" that links a traumatic event to a particular situation? A pair of researchers at the University of California, Riverside, may have found an answer.
Mar 13, 2020
0
648
Tumors have figured out various ways to prevent the immune system from attacking them. Medicine, for its part, has fought back with cancer immunotherapies. The major approach uses checkpoint inhibitors, drugs that help the ...
Mar 11, 2020
0
114
City of Hope scientists have developed and tested the first chimeric antigen receptor (CAR) T cell therapy using chlorotoxin (CLTX), a component of scorpion venom, to direct T cells to target brain tumor cells, according ...
Mar 4, 2020
0
46
